Oklahoma Medical Research Foundation

Oklahoma Medical Research Foundation
NicknameOMRF
Formation1946; 78 years ago (1946)
TypeNonprofit organization, independent research institution
73-0580274
Legal status501(c)3) Nonprofit Organization
PurposeMedical Research
HeadquartersOklahoma City, OK USA
President
Andrew S. Weyrich, Ph.D.
Budget
$92,338,587 USD
Staff450
Websiteomrf.org

The Oklahoma Medical Research Foundation (OMRF), located in the Oklahoma Health Center in Oklahoma City, Oklahoma, is an independent, nonprofit biomedical research institute. Established in 1946, OMRF is dedicated to understanding and developing more effective treatments for human disease. Andrew S. Weyrich, Ph.D. serves as president of OMRF,[1] which employs more than 500 scientific and administrative staff members.

OMRF's scientists, who include a member of the National Academy of Sciences, hold more than 700 U.S. and international patents and have spun off 11 biotech companies. Discoveries at OMRF led to Xigris, the first FDA-approved drug for the treatment of severe sepsis, and Ceprotin, a therapy for people suffering from a rare and life-threatening blood disorder known as protein C deficiency. Research at OMRF also identified the enzyme believed responsible for Alzheimer's disease and laid the groundwork for OncoVue,[2] a breast cancer risk assessment test.

  1. ^ Branham, Dana. "University of Utah research leader will be OMRF's next president". The Oklahoman. Retrieved 2022-02-17.
  2. ^ "What is OncoVue?". Intergenetics Inc. Archived from the original on April 26, 2005. Retrieved 2012-12-09.